Literature DB >> 24717355

Border maneuvers: deployment of mucosal immune defenses against Toxoplasma gondii.

S B Cohen1, E Y Denkers1.   

Abstract

Toxoplasma gondii is a highly prevalent protozoan pathogen that is transmitted through oral ingestion of infectious cysts. As such, mucosal immune defenses in the intestine constitute the first and arguably most important line of resistance against the parasite. The response to infection is now understood to involve complex three-way interactions between Toxoplasma, the mucosal immune system, and the host intestinal microbiota. Productive outcome of these interactions ensures resolution of infection in the intestinal mucosa. Nonsuccessful outcome may result in emergence of proinflammatory damage that can spell death for the host. Here, we discuss new advances in our understanding of the mechanisms underpinning these disparate outcomes, with particular reference to initiators, effectors, and regulators of mucosal immunity stimulated by Toxoplasma in the intestine.

Entities:  

Mesh:

Year:  2014        PMID: 24717355     DOI: 10.1038/mi.2014.25

Source DB:  PubMed          Journal:  Mucosal Immunol        ISSN: 1933-0219            Impact factor:   7.313


  110 in total

Review 1.  Insights into inflammatory bowel disease using Toxoplasma gondii as an infectious trigger.

Authors:  Charlotte E Egan; Sara B Cohen; Eric Y Denkers
Journal:  Immunol Cell Biol       Date:  2011-11-08       Impact factor: 5.126

2.  Reduced Paneth cell alpha-defensins in ileal Crohn's disease.

Authors:  Jan Wehkamp; Nita H Salzman; Edith Porter; Sabine Nuding; Michael Weichenthal; Robert E Petras; Bo Shen; Elke Schaeffeler; Matthias Schwab; Rose Linzmeier; Ryan W Feathers; Hiutung Chu; Heriberto Lima; Klaus Fellermann; Tomas Ganz; Eduard F Stange; Charles L Bevins
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-05       Impact factor: 11.205

3.  Induction of dendritic cell migration upon Toxoplasma gondii infection potentiates parasite dissemination.

Authors:  Henrik Lambert; Niclas Hitziger; Isabel Dellacasa; Mattias Svensson; Antonio Barragan
Journal:  Cell Microbiol       Date:  2006-10       Impact factor: 3.715

4.  In the absence of endogenous IFN-gamma, mice develop unimpaired IL-12 responses to Toxoplasma gondii while failing to control acute infection.

Authors:  T M Scharton-Kersten; T A Wynn; E Y Denkers; S Bala; E Grunvald; S Hieny; R T Gazzinelli; A Sher
Journal:  J Immunol       Date:  1996-11-01       Impact factor: 5.422

Review 5.  Paneth cells: maestros of the small intestinal crypts.

Authors:  Hans C Clevers; Charles L Bevins
Journal:  Annu Rev Physiol       Date:  2013       Impact factor: 19.318

6.  Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid.

Authors:  Daniel Mucida; Yunji Park; Gisen Kim; Olga Turovskaya; Iain Scott; Mitchell Kronenberg; Hilde Cheroutre
Journal:  Science       Date:  2007-06-14       Impact factor: 47.728

Review 7.  Regulation and function of T-cell-mediated immunity during Toxoplasma gondii infection.

Authors:  E Y Denkers; R T Gazzinelli
Journal:  Clin Microbiol Rev       Date:  1998-10       Impact factor: 26.132

8.  Expression of the zinc finger transcription factor zDC (Zbtb46, Btbd4) defines the classical dendritic cell lineage.

Authors:  Matthew M Meredith; Kang Liu; Guillaume Darrasse-Jeze; Alice O Kamphorst; Heidi A Schreiber; Pierre Guermonprez; Juliana Idoyaga; Cheolho Cheong; Kai-Hui Yao; Rachel E Niec; Michel C Nussenzweig
Journal:  J Exp Med       Date:  2012-05-21       Impact factor: 14.307

9.  Disruption of Toxoplasma gondii parasitophorous vacuoles by the mouse p47-resistance GTPases.

Authors:  Sascha Martens; Iana Parvanova; Jens Zerrahn; Gareth Griffiths; Gudrun Schell; Gaby Reichmann; Jonathan C Howard
Journal:  PLoS Pathog       Date:  2005-11-18       Impact factor: 6.823

10.  Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid.

Authors:  Cheng-Ming Sun; Jason A Hall; Rebecca B Blank; Nicolas Bouladoux; Mohamed Oukka; J Rodrigo Mora; Yasmine Belkaid
Journal:  J Exp Med       Date:  2007-07-09       Impact factor: 14.307

View more
  8 in total

1.  Impact of Toxoplasma gondii on Dendritic Cell Subset Function in the Intestinal Mucosa.

Authors:  Sara B Cohen; Eric Y Denkers
Journal:  J Immunol       Date:  2015-08-17       Impact factor: 5.422

Review 2.  From Entry to Early Dissemination-Toxoplasma gondii's Initial Encounter With Its Host.

Authors:  Estefania Delgado Betancourt; Benjamin Hamid; Benedikt T Fabian; Christian Klotz; Susanne Hartmann; Frank Seeber
Journal:  Front Cell Infect Microbiol       Date:  2019-03-05       Impact factor: 5.293

Review 3.  Pathophysiology of ocular toxoplasmosis: Facts and open questions.

Authors:  Valentin Greigert; Faiza Bittich-Fahmi; Alexander W Pfaff
Journal:  PLoS Negl Trop Dis       Date:  2020-12-31

Review 4.  Anti-Toxoplasma gondii IgM Long Persistence: What Are the Underlying Mechanisms?

Authors:  José Antonio Vargas-Villavicencio; Irma Cañedo-Solares; Dolores Correa
Journal:  Microorganisms       Date:  2022-08-17

Review 5.  Intestinal immune responses to commensal and pathogenic protozoa.

Authors:  Aline Sardinha-Silva; Eliza V C Alves-Ferreira; Michael E Grigg
Journal:  Front Immunol       Date:  2022-09-16       Impact factor: 8.786

Review 6.  The Interplay of Host Microbiota and Parasitic Protozoans at Mucosal Interfaces: Implications for the Outcomes of Infections and Diseases.

Authors:  Ann-Katrein Bär; Niha Phukan; Jully Pinheiro; Augusto Simoes-Barbosa
Journal:  PLoS Negl Trop Dis       Date:  2015-12-10

Review 7.  Parasite-Microbiota Interactions With the Vertebrate Gut: Synthesis Through an Ecological Lens.

Authors:  Jacqueline M Leung; Andrea L Graham; Sarah C L Knowles
Journal:  Front Microbiol       Date:  2018-05-14       Impact factor: 5.640

8.  Toxoplasma gondii Manipulates Expression of Host Long Noncoding RNA during Intracellular Infection.

Authors:  Kayla L Menard; Breanne E Haskins; Anthony P Colombo; Eric Y Denkers
Journal:  Sci Rep       Date:  2018-10-09       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.